尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Overseas Regulatory Announcement-Announcement on Memantine Hydrochloride Tablets
2024-01-19
Next Day Disclosure Return
2024-01-15
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
2024-01-02
List of Directors And Their Roles And Functions
2023-12-22
Renewal of Continuing Connected Transaction In Relation To Trademark Licence Agr
2023-12-22
Poll Results of the General Meeting And Re-election of Directors And Supervisors; Members of The Board Committees;And Re-Appointment of Senior Management
2023-12-22
Overseas Regulatory Announcement-Announcement on Levamlodiping Besylate Tablets
2023-12-13
Overseas Regulatory Announcement-Announcement on Cefixime Capsules Passing the G
2023-12-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
2023-12-01
Reply Slip for the Extraordinary General Meeting
2023-11-30
<
...
6
7
8
9
10
11
12
...
>